Expression of transforming growth factor-β1 limits renal ischemia-reperfusion injury

Transplantation

Volumn 89, Issue 11, 2010, Pages 1320-1327

  Guan, Qiunong ^a   Nguan, Christopher Y C ^a,b   Du, Caigan ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Ischemia reperfusion injury; Kidney; TGF ; TNF .

Indexed keywords

CREATININE; NITROGEN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE DISORDER; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WILD TYPE;

ANIMALS; APOPTOSIS; CELL DEATH; CELL LINE; DNA PRIMERS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GENES, BCL-2; HUMANS; KIDNEY; KIDNEY TUBULES, PROXIMAL; MICE; MICE, KNOCKOUT; MICRORNAS; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77953361022     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d8e9dc     Document Type: Article

References (66)

1. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005; 16: 3015.
2. Peeters P, Terryn W, Vanholder R, et al. Delayed graft function in renal transplantation. Curr Opin Crit Care 2004; 10: 489.
3. Perco P, Pleban C, Kainz A, et al. Gene expression and biomarkers in renal transplant ischemia reperfusion injury. Transpl Int 2007; 20: 2.
4. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109: e102.
5. Bellomo R, Auriemma S, Fabbri A, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 2008; 31: 166.
6. Kellum JA, Bellomo R, Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract 2008; 109: c182.
7. Gobe G, Willgoss D, Hogg N, et al. Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 1999; 56: 1299.
8. Savill J. Apoptosis and the kidney. J Am Soc Nephrol 1994; 5: 12.
9. Schumer M, Colombel MC, Sawczuk IS, et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992; 140: 831.
10. Basile DP, Fredrich K, Alausa M, et al. Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. AmJ Physiol Renal Physiol2005; 288: F953.
11. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 2003; 14(suppl 1): S55.
12. Harris RC. Growth factors and cytokines in acute renal failure. Adv Ren Replace Ther 1997; 4(2 suppl 1): 43.
13. Honda N, Hishida A, Kato A. Factors affecting severity of renal injury and recovery of function in acute renal failure. Ren Fail 1992; 14: 337.
14. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597.
15. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3: 807.
16. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009; 21: 166.
17. Bottinger EP. TGF-beta in renal injury and disease. Semin Nephrol 2007; 27: 309.
18. Docherty NG, Perez-Barriocanal F, Balboa NE, et al. Transforming growth factor-beta1 (TGF-beta1): A potential recovery signal in the post-ischemic kidney. Ren Fail 2002; 24: 391.
19. Basile DP, Rovak JM, Martin DR, et al. Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol 1996; 270(3 Pt 2): F500.
20. Lario S, Mendes D, Bescos M, et al. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation. Transplantation 2003; 75: 1647.
21. Ryan MJ, Johnson G, Kirk J, et al. HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 1994; 45: 48.
22. Jevnikar AM, Brennan DC, Singer GG, et al. Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int 1991; 40: 203.
23. Du C, Guan Q, Diao H, et al. Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8. Am J Physiol Renal Physiol 2006; 290: F1044.
24. Du C, Wang S, Diao H, et al. Increasing resistance of tubular epithelial cells to apoptosis by shRNA therapy ameliorates renal ischemia-reperfusion injury. Am J Transplant 2006; 6: 2256.
25. Matsuo SE, Leoni SG, ColquhounA, et al. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells. J Endocrinol 2006; 190: 141.
26. Ando T, Okuda S, Tamaki K, et al. Localizationof transforming growth factor-beta and latent transforming growth factor-beta binding protein in rat kidney. Kidney Int 1995; 47: 733.
27. Gentry LE, Webb NR, Lim GJ, et al. Type 1 transforming growth factor beta: Amplified expression and secretion of mature and precursor polypeptidesinChinese hamster ovary cells.Mol Cell Biol1987;7:3418.
28. Miyazono K, Hellman U, Wernstedt C, et al. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol Chem 1988; 263: 6407.
29. Daemen MA, van de Ven MW, Heineman E, et al. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation 1999; 67: 792.
30. Donnahoo KK, Meng X,Ayala A, et al. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999; 277(3 Pt 2): R922.
31. Gobe G, Zhang XJ, Willgoss DA, et al. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000; 11: 454.
32. Spurgeon KR, Donohoe DL, Basile DP. Transforming growth factor-beta in acute renal failure: Receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury. Am J Physiol Renal Physiol 2005; 288: F568.
33. Bhaskaran M, Reddy K, Radhakrishanan N, et al. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003; 284: F955.
34. Dai C, Yang J, Liu Y. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of SMAD signaling. J Biol Chem 2003; 278: 12537.
35. Miyajima A, Chen J, Lawrence C, et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000; 58: 2301.
36. Ling H, Li X, Jha S, et al. Therapeutic role of TGF-beta-neutralizing antibodyin mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation. J Am Soc Nephrol 2003; 14: 377.
37. MiyajimaA,AsanoT,AsanoT,et al. Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol 2001; 165: 1714.
38. Lee HT, Kim M, Kim J, et al. TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis. Am J Nephrol 2007; 27: 416.
39. Lee HT, Ota-Setlik A, Fu Y, et al. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004; 101: 1313.
40. Danielpour D, Kim KY, Winokur TS, et al. Differential regulation of the expression of transforming growth factor-beta s 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J Cell Physiol 1991; 148: 235.
41. Di Paolo S, Gesualdo L, Ranieri E, et al. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol 1996; 149: 2095.
42. Phillips AO, Steadman R, Topley N, et al. Elevated D-glucose concentrations modulate TGF-beta 1synthesis byhuman cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor. Am J Pathol 1995; 147: 362.
43. Yamabe H, Osawa H, Kaizuka M, et al. Platelet-derived growth factor, basic fibroblast growth factor, and interferon gamma increase type IV collagen production in human fetal mesangial cells via a transforming growth factor-beta-dependent mechanism. Nephrol Dial Transplant 2000; 15: 872.
44. Phillips AO, Topley N, Morrisey K, et al. Basic fibroblast growth factor stimulates the release of preformed transforming growth factor beta 1 from human proximal tubular cells in the absence of de novo gene transcription or mRNA translation. Lab Invest 1997; 76: 591.
45. Nakagawa T, Sasahara M, Haneda M, et al. Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury. Am J Pathol 1999; 155: 1689.
46. Schaudies RP, Nonclercq D, Nelson L, et al. Endogenous EGF as a potential renotrophic factor in ischemia-induced acute renal failure. Am J Physiol 1993; 265(3 Pt 2): F425.
47. ToubeauG, Nonclercq D, Zanen J, et al. Renal tissue expression of EGF and EGF receptor after ischaemic tubular injury: An immunohisto-chemical study. Exp Nephrol 1994; 2: 229.
48. Villanueva S, Cespedes C, Gonzalez A, et al. bFGF induces an earlier expression of nephrogenic proteins after ischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol 2006; 291: R1677.
49. Humes HD, Cieslinski DA, Coimbra TM, et al. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 1989; 84: 1757.
50. Dockrell ME, Phanish MK, Hendry BM. Tgf-beta auto-induction and connective tissue growth factor expression in human renal tubule epithelial cells requires N-ras. Nephron Exp Nephrol 2009; 112: e71.
51. Grande JP, Warner GM, Walker HJ, et al. TGF-beta1 is an autocrine mediator of renal tubular epithelial cell growth and collagen IV production. Exp Biol Med (Maywood) 2002; 227: 171.
52. Nowak G, Schnellmann RG. Autocrine production and TGF-beta 1-mediated effects on metabolism and viability in renal cells. Am J Physiol 1996; 271(3 Pt 2): F689.
53. Ruiz-Ortega M,Largo R, Bustos C, et al. Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Am Soc Nephrol 1997; 8: 1266.
54. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 2001; 59: 87.
55. Vesey DA, Cheung C, Cuttle L, et al. Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. J Lab Clin Med 2002; 140: 342.
56. Vesey DA, Cheung CW, Cuttle L, et al. Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int 2002; 62: 31.
57. Jo SK, Sung SA, Cho WY, et al. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 2006; 21: 1231.
58. Lopez-Novoa JM. Potential role of platelet activating factor in acute renal failure. Kidney Int 1999; 55: 1672.
59. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156.
60. Wiggins MC, Bracher M, Mall A, et al. Tumour necrosis factor levels during acute rejection and acute tubular necrosis in renal transplant recipients. Transpl Immunol 2000; 8: 211.
61. Ficek R, Kokot F, Chudek J, et al. Plasma concentrations of tumor necrosis factor alpha may predict the outcome of patients with acute renal failure. Kidney Blood Press Res 2006; 29: 203.
62. Sonkar GK, Usha, Singh RG. Evaluation of serum tumor necrosis factor alpha and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases. Saudi J Kidney Dis Transpl 2009; 20: 1000.
63. Winyard PJ, Nauta J, Lirenman DS, et al. Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 1996; 49: 135.
64. Gobe G, Zhang XJ, Cuttle L, et al. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure. Immunol Cell Biol 1999; 77: 279.
65. Lu Q. Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5. Am J Physiol Lung Cell Mol Physiol 2008; 295: L123.
66. Park SM, Jung JS, Jang MS, et al. Transforming growth factor-beta1 regulates the fate of cultured spinal cord-derived neural progenitor cells. Cell Prolif 2008; 41: 248.